Clinical context
A patient receiving
parenteral nutrition (PN) that contains
regular insulin is at risk for
rebound hypoglycemia if the infusion is interrupted abruptly. The PN solution provides a continuous supply of concentrated dextrose, which drives endogenous insulin secretion; the added regular insulin further increases circulating insulin. When the bag runs out and the next one is delayed, the dextrose source disappears while insulin action persists, creating a mismatch that can rapidly lower blood glucose.
Why option 2 is the best action
Hanging
dextrose 10% in water (D10W) at the same rate of
80 mL/h replaces the carbohydrate delivery that was being provided by the PN. This prevents the sudden drop in glucose that would otherwise occur when the dextrose-containing PN is stopped while insulin is still active. The key principle is that
the dextrose infusion must continue at a rate that approximates the PN dextrose load until the next PN bag is available. Simply monitoring glucose does not prevent hypoglycemia; it only detects it after the fact.
Why the other options are insufficient
| Option | Problem |
|---|
| 1. Stop infusion and check glucose hourly | Stopping the dextrose source while insulin remains active invites hypoglycemia. Hourly checks detect falling glucose but do not prevent the drop. |
| 3. 0.9% sodium chloride at 80 mL/h | Normal saline keeps the lumen patent but provides no dextrose. It does not address the metabolic risk of rebound hypoglycemia. |
| 4. D5W at keep-open rate of 20 mL/h | D5W at only 20 mL/h delivers far less dextrose than the PN was providing at 80 mL/h. The rate is too low to match the previous carbohydrate load and may be insufficient to prevent hypoglycemia. |
Pathophysiology of rebound hypoglycemia
PN solutions typically contain high concentrations of dextrose, often
20–25% or more depending on the formulation. This hyperosmolar dextrose load stimulates the pancreas to release endogenous insulin. When regular insulin is also added to the PN bag, the total insulin effect is amplified. If the PN infusion stops suddenly, the dextrose supply is cut off, but the insulin already in circulation continues to drive glucose into cells and suppress hepatic glucose output. The result is a rapid fall in serum glucose, which can occur within
30–60 minutes after stopping the infusion.
Key point! The patient’s midnight glucose of
162 mg/dL (
9.0 mmol/L) is mildly elevated but does not protect against rebound hypoglycemia. The glucose level can drop quickly once the dextrose source is removed while insulin remains active.
Nursing and safety considerations
When a PN bag is unavailable, the replacement dextrose infusion should be administered through the same dedicated lumen used for PN to avoid incompatibility or rate fluctuations. The infusion pump must be programmed to deliver the ordered rate accurately. Blood glucose monitoring should continue, but it is an adjunct to—not a substitute for—maintaining dextrose delivery.
The priority is to prevent the hypoglycemic event rather than to detect it after it develops.
Watch out! Do not confuse keeping the line open with maintaining metabolic stability. A keep-open rate of saline or D5W may prevent catheter occlusion, but it does not replace the dextrose load that was suppressing the patient’s own insulin-driven glucose disposal. The rate and dextrose concentration must be sufficient to approximate the carbohydrate delivery of the original PN.
Application to nursing licensure exams
This scenario tests the ability to recognize an iatrogenic risk created by a therapy interruption. The correct response is not simply to monitor or to maintain line patency, but to actively replace the missing substrate. In exam terms,
the action that directly prevents the complication is prioritized over actions that only assess or observe. The same principle applies to other continuous infusions with metabolic consequences, such as insulin drips or high-dextrose fluids.